RxSight Statistics

Total Valuation

RxSight has a market cap or net worth of $221.89 million. The enterprise value is $14.83 million.

Market Cap	221.89M
Enterprise Value	14.83M

Important Dates

The next estimated earnings date is Thursday, August 6, 2026, after market close.

Earnings Date	Aug 6, 2026
Ex-Dividend Date	n/a

Share Statistics

RxSight has 41.40 million shares outstanding. The number of shares has increased by 3.18% in one year.

Current Share Class	41.40M
Shares Outstanding	41.40M
Shares Change (YoY)	+3.18%
Shares Change (QoQ)	+0.32%
Owned by Insiders (%)	5.57%
Owned by Institutions (%)	93.57%
Float	39.09M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.74
Forward PS	1.67
PB Ratio	0.83
P/TBV Ratio	0.83
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	0.12
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.20, with a Debt / Equity ratio of 0.04.

Current Ratio	10.20
Quick Ratio	8.78
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-3,459.13

Financial Efficiency

Return on equity (ROE) is -17.06% and return on invested capital (ROIC) is -93.15%.

Return on Equity (ROE)	-17.06%
Return on Assets (ROA)	-11.21%
Return on Invested Capital (ROIC)	-93.15%
Return on Capital Employed (ROCE)	-20.01%
Weighted Average Cost of Capital (WACC)	10.01%
Revenue Per Employee	$276,523
Profits Per Employee	-$101,167
Employee Count	461
Asset Turnover	0.41
Inventory Turnover	1.00

Taxes

In the past 12 months, RxSight has paid $54,000 in taxes.

Income Tax	54,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -59.33% in the last 52 weeks. The beta is 1.13, so RxSight's price volatility has been higher than the market average.

Beta (5Y)	1.13
52-Week Price Change	-59.33%
50-Day Moving Average	5.90
200-Day Moving Average	8.26
Relative Strength Index (RSI)	51.92
Average Volume (20 Days)	1,128,223

Short Selling Information

The latest short interest is 4.18 million, so 10.10% of the outstanding shares have been sold short.

Short Interest	4.18M
Short Previous Month	4.17M
Short % of Shares Out	10.10%
Short % of Float	10.69%
Short Ratio (days to cover)	4.63

Income Statement

In the last 12 months, RxSight had revenue of $127.48 million and -$46.64 million in losses. Loss per share was -$1.14.

Revenue	127.48M
Gross Profit	98.18M
Operating Income	-55.35M
Pretax Income	-46.58M
Net Income	-46.64M
EBITDA	-52.02M
EBIT	-55.35M
Loss Per Share	-$1.14

Full Income Statement

Balance Sheet

The company has $217.88 million in cash and $10.83 million in debt, giving a net cash position of $207.05 million or $5.00 per share.

Cash & Cash Equivalents	217.88M
Total Debt	10.83M
Net Cash	207.05M
Net Cash Per Share	$5.00
Equity (Book Value)	267.30M
Book Value Per Share	6.46
Working Capital	251.85M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$17.57 million and capital expenditures -$4.01 million, giving a free cash flow of -$21.58 million.

Operating Cash Flow	-17.57M
Capital Expenditures	-4.01M
Depreciation & Amortization	3.32M
Net Borrowing	-20,000
Free Cash Flow	-21.58M
FCF Per Share	-$0.52

Full Cash Flow Statement

Margins

Gross margin is 77.02%, with operating and profit margins of -43.42% and -36.59%.

Gross Margin	77.02%
Operating Margin	-43.42%
Pretax Margin	-36.54%
Profit Margin	-36.59%
EBITDA Margin	-40.81%
EBIT Margin	-43.42%
FCF Margin	n/a

Dividends & Yields

RxSight does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.18%
Shareholder Yield	-3.18%
Earnings Yield	-21.02%
FCF Yield	-9.73%

Analyst Forecast

The average price target for RxSight is $8.79, which is 63.99% higher than the current price. The consensus rating is "Hold".

Price Target	$8.79
Price Target Difference	63.99%
Analyst Consensus	Hold
Analyst Count	9
Revenue Growth Forecast (3Y)	4.84%
EPS Growth Forecast (3Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

RxSight has an Altman Z-Score of 4.73 and a Piotroski F-Score of 2.

Altman Z-Score	4.73
Piotroski F-Score	2